METHUSELAH ARCHIVE SOURCES / FDA-TESLA-BIOHEALING-WARNING-LETTER-FACSIMILE-2023

Tesla BioHealing, Inc. warning-letter webpage facsimile

photograph · 2023
type:photograph
year:2023
citation:U.S. Food and Drug Administration. 'Tesla BioHealing, Inc. MARCS-CMS 658010 — August 10, 2023.' Webpage facsimile captured by Methuselah Archive, July 24, 2026.
LINK
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tesla-biohealing-inc-658010-08102023
SUMMARY
Screen capture of the live FDA warning-letter page, read directly on 24 July 2026. The crop preserves the document heading, date, delivery and product metadata, the recipient block naming James Zhou Liu as CEO of Tesla BioHealing, Inc., the issuing office, and the opening paragraph naming the Tesla MedBed Generator and Tesla BioHealer devices. The displayed document is an FDA-authored U.S. federal government work; Methuselah Archive created the crop and releases its screen capture under CC0.
NOTES

This facsimile is the disconfirmation-stage artifact for the Tesla BioHealing case. The separate fda-tesla-biohealing-warning-letter-2023 Source record carries the warning letter’s substantive regulatory findings and full evidentiary summary.